Yujing Li

3PUBLICATIONS
27CO-AUTHORS
Applied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)AutoimmunityMolecular targets
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (3)

|Aug 22, 2025
Reprogramming intratumoral Treg cells by morpholino-mediated splicing of FOXP3 for cancer immunotherapy.

Yujing Li, Naresh Singh, Chuanpeng Dong

|Jun 24, 2022
FOXP3 exon 2 controls Treg stability and autoimmunity.

Jianguang Du, Qun Wang, Shuangshuang Yang

|Feb 11, 2021
Targeted immunotherapy for HER2-low breast cancer with 17p loss.

Yujing Li, Yifan Sun, Michael Kulke

Pageof 1